Exact Mass: 478.1805
Exact Mass Matches: 478.1805
Found 314 metabolites which its exact mass value is equals to given mass value 478.1805
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Enterodiol glucuronide
Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1H-1,2,4-triazol-1-ylmethyl)-3-quinolinecarboxylate
Calcium pantothenate
Nutrient supplement, may be used in infant formulas. Enzyme cofactor vitamin. Pantothenic acid is a water-soluble vitamin. For many animals, pantothenic acid is an essential nutrient. Only the dextrorotatory (D) isomer of pantothenic acid possesses biologic activity. The levorotatory (L) form may antagonize the effects of the dextrorotatory isomer. Nutrient supplement, may be used in infant formulas. Enzyme cofactor vitamin
(2S)-7-hydroxy-8-hydroxyethyl-4-methoxyflavane-2-O-beta-D-glucopyranoside|7,2-dihydroxy-8-hydroxyethyl-4-methoxyflavane-2-O-beta-D-glucopyranoside
(2S)-7-methoxy-8-hydroxyethyl-4-hydroxyflavane-2-O-beta-D-glucopyranoside
10alpha-acetoxy-8alpha-methacroyloxy-1alpha-methoxyhirsutinolide-13-O-acetate
6beta,9beta-diacetoxy-4(15)-en-1alpha,10alpha-epoxy-5alpha-(2-methylbutyryloxy)-2-oxo-7,8alpha-germacranolide
(2E)-3-phenylprop-2-enoic acid [(1S,4aR,5S,7aS,)-1-(beta-D-glucopyranosyloxy)-1,3-4,4a,5,7a-hexahydro-5-hydroxycyclopenta[c]pyran-7-yl]methyl ester|sintenoside
2alpha,13-diacetoxy-8alpha-angeloyloxy-4alpha,14-dihydroxygermacra-1(10)E,5E,7(11)-trien-12,6-olide
(7R,8R)-3-methoxyl-9-O-beta-D-xylopyranosyl-4:7,5:8-diepoxyneodiepoxyneolignan-4,9-diol
(2E)-3-phenylprop-2-enoic acid rel-(1R,4aR,7R,7aR)-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a-hydroxy-7-methylcylopenta[c]pyran-7-yl ester|6-deoxyharpagoside|corvifloruside E
(3aR,4S,5aR,6R,9R,9bR)-9-formyldodecahydro-6-hydroxy-5a-methyl-3-methylidene-2-oxonaphtho[1,2-b]furan-4-yl 4-(acetyloxy)-2-[(acetyloxy)methyl]but-2-enoate|8alpha-O-(4,5-diacetoxyangeloyl)sonchucarpolide
3-alpha-acetoxymaoesin A|3alpha,19-diacetoxy-6alpha,20-dihydroxy-6,11beta-epoxy-15-oxo-6,7-seco-ent-kaur-16-en-1beta,7-olide
(5S)-1,7-bis(3,4-dihydroxyphenyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyheptan-3-one
(2S,3R,4S,5R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
(2S,3R,4S,5R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
(5S)-1,7-bis(3,4-dihydroxyphenyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyheptan-3-one [IIN-based: Match]
8-2-Amino-3,8-dimmethylimidazo[4,5-f]quinoxaline-deoxyguanosine
(2S,3R,4S,5R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol_major
Ala Glu Glu Met
Ala Glu Met Glu
Ala Met Glu Glu
Cys Asp Glu Ile
Cys Asp Glu Leu
Cys Asp Ile Glu
Cys Asp Lys Asn
Cys Asp Leu Glu
Cys Asp Asn Lys
Cys Glu Asp Ile
Cys Glu Asp Leu
Cys Glu Glu Val
Cys Glu Ile Asp
Cys Glu Leu Asp
Cys Glu Val Glu
Cys Ile Asp Glu
Cys Ile Glu Asp
Cys Lys Asp Asn
Cys Lys Asn Asp
Cys Leu Asp Glu
Cys Leu Glu Asp
Cys Asn Asp Lys
Cys Asn Lys Asp
Cys Pro Pro Tyr
Cys Pro Tyr Pro
Cys Gln Gln Thr
Cys Gln Thr Gln
Cys Thr Gln Gln
Cys Val Glu Glu
Cys Tyr Pro Pro
Asp Cys Glu Ile
Asp Cys Glu Leu
Asp Cys Ile Glu
Asp Cys Lys Asn
Asp Cys Leu Glu
Asp Cys Asn Lys
Asp Asp Met Val
Asp Asp Val Met
Asp Glu Cys Ile
Asp Glu Cys Leu
Asp Glu Ile Cys
Asp Glu Leu Cys
Asp Ile Cys Glu
Asp Ile Glu Cys
Asp Lys Cys Asn
Asp Lys Asn Cys
Asp Leu Cys Glu
Asp Leu Glu Cys
Asp Met Asp Val
Asp Met Val Asp
Asp Asn Cys Lys
Asp Asn Lys Cys
Asp Val Asp Met
Asp Val Met Asp
Glu Ala Glu Met
Glu Ala Met Glu
Glu Cys Asp Ile
Glu Cys Asp Leu
Glu Cys Glu Val
Glu Cys Ile Asp
Glu Cys Leu Asp
Glu Cys Val Glu
Glu Asp Cys Ile
Glu Asp Cys Leu
Glu Asp Ile Cys
Glu Asp Leu Cys
Glu Glu Ala Met
Glu Glu Cys Val
Glu Glu Met Ala
Glu Glu Val Cys
Glu Ile Cys Asp
Glu Ile Asp Cys
Glu Leu Cys Asp
Glu Leu Asp Cys
Glu Met Ala Glu
Glu Met Glu Ala
Glu Val Cys Glu
Glu Val Glu Cys
Ile Cys Asp Glu
Ile Cys Glu Asp
Ile Asp Cys Glu
Ile Asp Glu Cys
Ile Glu Cys Asp
Ile Glu Asp Cys
Lys Cys Asp Asn
Lys Cys Asn Asp
Lys Asp Cys Asn
Lys Asp Asn Cys
Lys Asn Cys Asp
Lys Asn Asp Cys
Leu Cys Asp Glu
Leu Cys Glu Asp
Leu Asp Cys Glu
Leu Asp Glu Cys
Leu Glu Cys Asp
Leu Glu Asp Cys
Met Ala Glu Glu
Met Asp Asp Val
Met Asp Val Asp
Met Glu Ala Glu
Met Glu Glu Ala
Met Asn Asn Thr
Met Asn Gln Ser
Met Asn Ser Gln
Met Asn Thr Asn
Met Gln Asn Ser
Met Gln Ser Asn
Met Ser Asn Gln
Met Ser Gln Asn
Met Thr Asn Asn
Met Val Asp Asp
Asn Cys Asp Lys
Asn Cys Lys Asp
Asn Asp Cys Lys
Asn Asp Lys Cys
Asn Lys Cys Asp
Asn Lys Asp Cys
Asn Met Asn Thr
Asn Met Gln Ser
Asn Met Ser Gln
Asn Met Thr Asn
Asn Asn Met Thr
Asn Asn Thr Met
Asn Gln Met Ser
Asn Gln Ser Met
Asn Ser Met Gln
Asn Ser Gln Met
Asn Thr Met Asn
Asn Thr Asn Met
Pro Cys Pro Tyr
Pro Cys Tyr Pro
Pro Pro Cys Tyr
Pro Pro Tyr Cys
Pro Tyr Cys Pro
Pro Tyr Pro Cys
Gln Cys Gln Thr
Gln Cys Thr Gln
Gln Met Asn Ser
Gln Met Ser Asn
Gln Asn Met Ser
Gln Asn Ser Met
Gln Gln Cys Thr
Gln Gln Thr Cys
Gln Ser Met Asn
Gln Ser Asn Met
Gln Thr Cys Gln
Gln Thr Gln Cys
Ser Met Asn Gln
Ser Met Gln Asn
Ser Asn Met Gln
Ser Asn Gln Met
Ser Gln Met Asn
Ser Gln Asn Met
Thr Cys Gln Gln
Thr Met Asn Asn
Thr Asn Met Asn
Thr Asn Asn Met
Thr Gln Cys Gln
Thr Gln Gln Cys
Val Cys Glu Glu
Val Asp Asp Met
Val Asp Met Asp
Val Glu Cys Glu
Val Glu Glu Cys
Val Met Asp Asp
Tyr Cys Pro Pro
Tyr Pro Cys Pro
Tyr Pro Pro Cys
7α-bromo-5,6β-epoxy-15β,16β-methylene-3β-pivaloyloxy-5β-androstan-17-one
3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide
Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1H-1,2,4-triazol-1-ylmethyl)-3-quinolinecarboxylate
1,4-Bis[2-(4-hydroxyphenyl)ethylamino]anthracene-9,10-dione
JFD00244 is a sirtuin 2 (SIRT2) inhibitor, with anti-tumor effect. JFD00244 is also a Nsp-16 inhibitor against SARS-CoV-2[1][2].
1-(3-Ethoxypropyl)-2-[2-furanyl(oxo)methyl]imino-10-methyl-5-oxo-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxylic acid ethyl ester
Phenylalanylaminodi(ethyloxy)ethyl benzenesulfonamideaminocarbonylbenzenesulfonamide
2-[4-[7-Hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
1,7-Bis(3,4-dihydroxyphenyl)-5-(3,4,5-trihydroxyoxan-2-yl)oxyheptan-3-one
(2r)-2-[[(1r,2s,3r,4r,5r)-4-Acetamido-2-[(2s,3r,4r,5s,6r)-3-Acetamido-6-(Hydroxymethyl)-4,5-Bis(Oxidanyl)oxan-2-Yl]oxy-6,8-Dioxabicyclo[3.2.1]octan-3-Yl]oxy]propanoic Acid
Calcium;3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid
3alpha-Acetoxymaoesin A, (rel)-
A natural product found in Isodon eriocalyx.
N-(3-dibenzofuranyl)-2-[2-oxo-2-(2,4,6-trimethylanilino)ethoxy]benzamide
N-[2-chloro-5-[ethyl(phenyl)sulfamoyl]phenyl]-2-[methyl-(1-methyl-4-piperidinyl)amino]acetamide
N-[2-[1,3-benzodioxol-5-yl-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamide
N-[3-[4-(4-chlorophenyl)piperazin-1-yl]propyl]-2-(7-oxo-2,8,10-triazatricyclo[7.4.0.02,6]trideca-1(9),3,5,10,12-pentaen-8-yl)acetamide
(2S,3S,5S)-2-[[2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2H-chromen-5-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3-[4-[(2S,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1-(2,4,6-trimethoxyphenyl)propan-1-one
N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
2-Methoxy-4-[2,3-dihydro-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-hydroxybenzofuran-2-yl]phenyl beta-D-xylopyranoside
YG1702
YG1702 is a potent ALDH18A1-specific inhibitor. YG1702 attenuates the growth of MYCN-amplified NB and down-regulates MYCN. YG1702 physically interacts with ALDH18A1 with a high affinity and might potentially affect its enzymatic activity[1].
(2s,3r,4s,5s,6r)-2-{2-[(2s)-7-hydroxy-8-(2-hydroxyethyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-5-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (3ar,4s,5r,8r,11ar)-8-hydroxy-10-(hydroxymethyl)-3-methylidene-5-[(2-methylprop-2-enoyl)oxy]-4-[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1s,5r,7s,7as)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-7-yl (2e)-3-phenylprop-2-enoate
1,7-bis(3,4-dihydroxyphenyl)-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]heptan-3-one
2,10-bis(acetyloxy)-3-methyl-8,12-dimethylidene-6,13-dioxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-9-yl 2-methylbutanoate
2-{[2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2h-1-benzopyran-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1-{2-[2-(3,4-dimethoxyphenyl)ethyl]-6-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl}ethanone
(1r,2s,3r,5r,9r,10r,11r)-2,10-bis(acetyloxy)-3-methyl-8,12-dimethylidene-6,13-dioxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-9-yl (2r)-2-methylbutanoate
(2s,3r,4s,5s,6r)-2-{[(2s)-2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2h-1-benzopyran-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-(acetyloxy)-12-[(acetyloxy)methyl]-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylbut-2-enoate
(2r,3r,4s,5s,6s)-2-(hydroxymethyl)-6-[(3,5,6,7-tetramethoxy-9,10-dihydrophenanthren-2-yl)oxy]oxane-3,4,5-triol
(2s,3s,4s,5s,6s)-2-{[(2r)-2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2h-1-benzopyran-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{2-[(2s)-7-hydroxy-8-(2-hydroxyethyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-5-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-cinnamoylmyoporoside
{"Ingredient_id": "HBIN013689","Ingredient_name": "8-cinnamoylmyoporoside","Alias": "NA","Ingredient_formula": "C24H30O10","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)OC(=O)C=CC4=CC=CC=C4","Ingredient_weight": "478.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3711","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101402540","DrugBank_id": "NA"}